Henrik Andersson

Henrik Andersson

Auto-generated profile, based on publicly available information

Henrik Andersson

Linköping University

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 April 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
DVDeepti Verma
Deepti Verma
ESEva Särndahl
Eva Särndahl
HAHenrik Andersson
Henrik Andersson
PEPer Eriksson
Per Eriksson
MFMats Fredrikson
Mats Fredrikson
PSPeter Söderkvist
Peter Söderkvist
The Q705K polymorphism in NLRP3 has been implicated in several chronic inflammatory diseases. In this study we determine the functional role of this commonly occurring polymorphism using an in-vitro system. NLRP3-WT and NLRP3-Q705K were retrovirally transduced into the human monocytic cell line THP-1, followed by the assessment of IL-1β and IL-18 levels in the cell culture supernatant. THP-1 cells expressing the above NLRP3 variants were sorted based upon Green Fluorescent Protein (GFP) expression. Cytokine response to alum (one of the most widely used adjuvants in vaccines) in the cells stably expressing NLRP3-WT and NLRP3-Q705K were determined. IL-1β and IL-18 levels were found to be elevated in THP-1 cells transduced with NLRP3-Q705K compared to the NLRP3-WT. Upon exposure to alum, THP-1 cells stably expressing NLRP3-Q705K displayed an increased release of IL-1β, IL-18 and TNF-α, in a caspase-1 and IL-1 receptor-dependent manner. Collectively, these findings show that the Q705K polymorphism in NLRP3 is a gain-of-function alteration leading to an overactive NLRP3 inflammasome. The option of IL-1β blockade may be considered in patients with chronic inflammatory disorders that are unresponsive to conventional treatments.

20 November 2015 in BMC Cancer
Verified
Journal Article
Open access
PDF file
ISIvan Shabo
Ivan Shabo
KMKristine Midtbö
Kristine Midtbö
HAHenrik Andersson
Henrik Andersson
EÅEmma Åkerlund
Emma Åkerlund
HOHans Olsson
Hans Olsson
ALAnnelie Lindström
Annelie Lindström
Cell fusion is a natural process in normal development and tissue regeneration. Fusion between cancer cells and macrophages generates metastatic hybrids with genetic and phenotypic characteristics from both maternal cells. However, there are no clinical markers for detecting cell fusion in clinical context. Macrophage-specific antigen CD163 expression in tumor cells is reported in breast and colorectal cancers and proposed being caused by macrophages-cancer cell fusion in tumor stroma. The purpose of this study is to examine the cell fusion process as a biological explanation for macrophage phenotype in breast. Monocytes, harvested from male blood donor, were activated to M2 macrophages and co-cultured in ThinCert transwell system with GFP-labeled MCF-7 cancer cells. MCF7/macrophage hybrids were generated by spontaneous cell fusion, isolated by fluorescence-activated cell sorting and confirmed by fluorescence microscopy, short tandem repeats analysis and flow cytometry. CD163 expression was evaluated in breast tumor samples material from 127 women by immunohistochemistry. MCF-7/macrophage hybrids were generated spontaneously at average rate of 2 % and showed phenotypic and genetic traits from both maternal cells. CD163 expression in MCF-7 cells could not be induced by paracrine interaction with M2-activated macrophages. CD163 positive cancer cells in tumor sections grew in clonal collection and a cutoff point >25 % of positive cancer cells was significantly correlated to disease free and overall survival. In conclusion, macrophage traits in breast cancer might be caused by cell fusion rather than explained by paracrine cellular interaction. These data provide new insights into the role of cell fusion in breast cancer and contributes to the development of clinical markers to identify cell fusion.

1 March 2006 in Journal of Medical Microbiology
Verified
Journal Article
Open access
PDF file
HAHenrik Andersson
Henrik Andersson
BHBlanka Hartmanová
Blanka Hartmanová
RKRhonda KuoLee
Rhonda KuoLee
PRPatrik Rydén
Patrik Rydén
WCWayne Conlan
Wayne Conlan
Anders SjöstedtAnders Sjöstedt
Anders Sjöstedt
Tularaemia caused by inhalation of type A Francisella tularensis bacteria is one of the most aggressive infectious diseases known, but the reasons for the very rapid spread of the organism from the lungs to internal organs and the ensuing mortality are unknown. The present study used the mouse model to examine in detail the host immune response in the lung. After an aerosol challenge with 20 c.f.u. of the type A strain FSC033, all mice developed clinical signs of severe disease, showed weight loss by day 4 of infection and died the next day. Histopathological findings in the lung revealed acute inflammation and intense vasculitis and perivasculitis on day 4. Gene transcriptional changes in the mouse lung samples were examined on days 1, 2 and 4 of infection using a cDNA microarray with 20 600 mouse clones representing 18 500 genes. In total, 424 genes were found to be differentially expressed, some of which were both up- and downregulated at different time points, 192 of which were upregulated and 234 of which were downregulated for at least one time point. A high percentage of selected genes identified by the microarray analysis were confirmed to be differentially regulated by quantitative real-time PCR. Categorization of the differentially expressed genes showed that those preferentially involved in host immune responses were activated extensively on day 4 but hardly or not at all on days 1 and 2. Further analysis revealed that several of the genes upregulated on day 4 are known to depend on gamma interferon or tumour necrosis factor alpha for their regulation. In keeping with this finding, tumour necrosis factor alpha and gamma interferon levels were found to be increased significantly in bronchoalveolar lavage on day 4.

11 November 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JRJohanna Raffetseder
Johanna Raffetseder
EPElsje Pienaar
Elsje Pienaar
RBRobert Blomgran
Robert Blomgran
DEDaniel Eklund
Daniel Eklund
VBVeronika Patcha Brodin
Veronika Patcha Brodin
MLMaria Lerm
Maria Lerm
The standard treatment of tuberculosis (TB) takes six to nine months to complete and this lengthy therapy contributes to the emergence of drug-resistant TB. TB is caused by Mycobacterium tuberculosis (Mtb) and the ability of this bacterium to switch to a dormant phenotype has been suggested to be responsible for the slow clearance during treatment. A recent study showed that the replication rate of a non-virulent mycobacterium, Mycobacterium smegmatis, did not correlate with antibiotic susceptibility. However, the question whether this observation also holds true for Mtb remains unanswered. Here, in order to mimic physiological conditions of TB infection, we established a protocol based on long-term infection of primary human macrophages, featuring Mtb replicating at different rates inside the cells. During conditions that restricted Mtb replication, the bacterial phenotype was associated with reduced acid-fastness. However, these phenotypically altered bacteria were as sensitive to isoniazid, pyrazinamide and ethambutol as intracellularly replicating Mtb. In support of the recent findings with M. smegmatis, we conclude that replication rates of Mtb do not correlate with antibiotic tolerance.

24 October 2013 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
DEDaniel Eklund
Daniel Eklund
AWAmanda Welin
Amanda Welin
HAHenrik Andersson
Henrik Andersson
DVDeepti Verma
Deepti Verma
PSPeter Söderkvist
Peter Söderkvist
MLMaria Lerm
Maria Lerm
Activation of the NLRP3 inflammasome and subsequent generation of interleukin 1β is initiated in macrophages upon recognition of several stimuli. In the present work, we show that gain-of-function gene variants of inflammasome components known to predispose individuals to inflammatory disorders have a host-protective role during infection with Mycobacterium tuberculosis. By isolation of macrophages from patients and healthy blood donors with genetic variants in NLRP3 and CARD8 and subsequent infection of the cells with virulent M. tuberculosis, we show that these gene variants, combined, are associated with increased control of bacterial growth in human macrophages.

1 October 2010 in Journal of Biotechnology
Verified
Journal Article
Closed access
HAHenrik Andersson
Henrik Andersson
DSDaniella Steel
Daniella Steel
JAJulia Asp
Julia Asp
KDKerstin Dahlenborg
Kerstin Dahlenborg
MJMarianne Jonsson
Marianne Jonsson
CMCarl-Fredrik Mandenius
Carl-Fredrik Mandenius